MedTrace Logo

Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients

NCT01149577 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2010-06-23

No results posted yet for this study

Summary

Acute and sub-chronic administration of olanzapine has shown a favourable effect on the sleep disturbances in previously medicated schizophrenia patients with predominantly negative symptoms. The present study will be carried out to clarify the effect of olanzapine on polysomnographic profiles of schizophrenia patients in an acute phase of illness after controlling for the drug effects.

Conditions

Interventions

DRUG

Olanzapine

06 weeks treatment with Olanzapine in a flexible dosage schedule.

Sponsors & Collaborators

  • Central Institute of Psychiatry, Ranchi, India

    lead OTHER

Principal Investigators

  • Mohammad Zia Ul Haq Katshu, DPM · Central Institute of Psychiatry

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2007-12-31
Completion
2009-04-30

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01149577 on ClinicalTrials.gov